image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendation

Litigation Capital Management - Taking a bet on other people's lawsuits

April 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • LIT
  • Price:
  • 91.25p
Despite the general malaise affecting new issues, one sector that has been lively is litigation finance, with two new companies recently joining AIM - Manolete (MANO; 468p) and Litigation Capital Management. Both have seen very strong share price gains already; investors may have been influenced by the superb performance of Burford Capital (BUR; 1622p), the world’s largest litigation funder, which listed in 2009 and has spectacularly grown its pretax profits from US$34m in 2012 to US$315m in 2018, with operating margins up from 63% to 84%. Back in 2009 Burford had raised just £80m when it floated - less than half its £200m target. Fast-forward to December 2018 and it was able to raise U ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Litigation Capital Management (June 2019)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW